You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 10,383,853


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,383,853 protect, and when does it expire?

Patent 10,383,853 protects NUBEQA and is included in one NDA.

This patent has fourteen patent family members in twelve countries.

Summary for Patent: 10,383,853
Title:Carboxamide derivative and its diastereomers in stable crystalline form
Abstract: The present disclosure relates to solid crystalline forms of N--((S)-1-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)-propan-2-yl)-5-(1-- hydroxyethyl)-1H-pyrazole-3-carboxamide (I) and the diastereomers thereof, and to methods for preparing such crystalline forms. Compound (I) and the diastereomers thereof are potent androgen receptor (AR) modulators useful as a medicament. ##STR00001##
Inventor(s): Tormakangas; Olli (Turku, FI), Heikkinen; Terhi (Lieto, FI)
Assignee: Orion Corporation (Espoo, FI)
Application Number:15/997,028
Patent Claim Types:
see list of patent claims
Compound; Process;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,383,853: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and business professionals to navigate the complex landscape of intellectual property. This article will delve into the specifics of United States Patent 10,383,853, exploring its claims, scope, and the broader patent landscape.

Patent Overview

To begin, it is essential to identify the key elements of the patent in question. United States Patent 10,383,853, like any other patent, includes several critical components such as the abstract, claims, description, and drawings.

Abstract

The abstract provides a concise summary of the invention. It is a brief overview that helps in understanding the main subject matter without delving into the detailed description.

Claims

The claims section is the most critical part of a patent as it defines the scope of protection. Claims are statements that define the invention and distinguish it from prior art. There are two types of claims: independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[5].

Claim Analysis

Independent Claims

Independent claims in a patent like 10,383,853 are the broadest claims that define the invention. These claims are crucial because they set the boundaries of what is protected by the patent. For example, if a patent has an independent claim that describes a method for a specific process, any subsequent dependent claims will further detail or limit this method.

Dependent Claims

Dependent claims build upon the independent claims by adding additional limitations or features. These claims help to narrow down the scope of the invention and can make the patent more defensible against potential challenges.

Scope of the Patent

The scope of a patent is determined by its claims. Here are some key metrics and considerations:

Claim Length and Count

Research has shown that the length and count of independent claims can be indicative of the patent's scope. Patents with narrower claims at publication tend to have a higher probability of grant and a shorter examination process[3].

Patent Classification

Patents are classified using various systems such as the International Patent Classification (IPC) or the United States Patent Classification (USPC). These classifications help in understanding the broader technological area in which the patent resides. For instance, if a patent is classified under a specific IPC code, it indicates the field of technology to which the invention pertains[1].

Patent Landscape

Understanding the patent landscape involves analyzing the broader context in which the patent exists.

Prior Art and Citations

Prior art citations are crucial in determining the novelty and non-obviousness of an invention. Tools like the Common Citation Document (CCD) consolidate prior art cited by multiple patent offices, providing a comprehensive view of the prior art landscape[4].

Forward Citations

Forward citations, which are citations made to the patent by later patents, can indicate the impact and relevance of the invention. A high number of forward citations often suggests that the patent is influential in its field[3].

Inventorship and Assignee Data

Correctly determining inventorship is vital for the validity of a patent. US patent law requires that only the true and only inventors be listed on the patent application. This involves identifying who conceived the idea and reduced it to practice[2].

Disambiguated Data

Resources like PatentsView provide disambiguated data on inventors and assignees, which helps in accurately identifying the parties involved in the patent. This data can be crucial for legal and commercial purposes[1].

Patent Prosecution Process

The process of obtaining a patent involves several stages, each with its own challenges.

Provisional and Non-Provisional Applications

A provisional patent application can be filed first, followed by a non-provisional application within one year. This process allows for the early filing of an application while still refining the invention[5].

Examination and Appeal

During the examination process, a patent examiner reviews the application for patentability. If the application is not patentable as submitted, arguments and amended claims may be necessary. If the examiner's decision is unfavorable, an appeal can be made to an appeal board or the U.S. court system[5].

International Considerations

For inventions with global potential, international patent applications, such as those under the Patent Cooperation Treaty (PCT), can be filed. This preserves the right to file for a patent in 153 countries within 30 months of the earliest priority date[5].

Costs and Commercial Considerations

The cost of patenting can be significant, ranging from $8,000 to $20,000 for a U.S. non-provisional patent application, and much more for international patents. Commercial partners often cover these costs, especially if there is a high commercial value to the invention[5].

Key Takeaways

  • Claims Define Scope: The claims section of a patent is crucial for understanding the scope of protection.
  • Patent Classification: Understanding the classification of a patent helps in identifying its technological field.
  • Prior Art and Citations: Analyzing prior art and forward citations is essential for determining the novelty and impact of an invention.
  • Inventorship: Correctly identifying inventors is vital for the validity of a patent.
  • Prosecution Process: The patent prosecution process involves multiple stages, including examination and potential appeals.
  • International Considerations: International patent applications can be filed to protect inventions globally.

FAQs

Q: What is the importance of independent claims in a patent?

A: Independent claims define the broadest scope of the invention and are crucial for determining the boundaries of what is protected by the patent.

Q: How do prior art citations affect a patent application?

A: Prior art citations help in determining the novelty and non-obviousness of an invention. They are essential for the patent examiner to assess whether the invention is patentable.

Q: What is the difference between a provisional and a non-provisional patent application?

A: A provisional patent application allows for early filing and provides a one-year period to refine the invention before filing a non-provisional application.

Q: Why is correct inventorship important in a patent application?

A: Correct inventorship is vital because US patent law requires that only the true and only inventors be listed on the patent application to ensure the patent's validity.

Q: What is the role of the Patent Cooperation Treaty (PCT) in international patent applications?

A: The PCT preserves the right to file for a patent in 153 countries within 30 months of the earliest priority date, allowing for global protection of an invention.

Sources

  1. PatentsView: Data Download Tables - PatentsView.
  2. Oregon State University: Determining Inventorship for US Patent Applications.
  3. SSRN: Patent Claims and Patent Scope.
  4. USPTO: Search for patents - USPTO.
  5. KU Office of Research: Intellectual Property Protection - KU Office of Research.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,383,853

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bayer Healthcare NUBEQA darolutamide TABLET;ORAL 212099-001 Jul 30, 2019 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,383,853

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Finland20150033Jan 30, 2015

International Family Members for US Patent 10,383,853

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Denmark 3250554 ⤷  Subscribe
European Patent Office 3250554 ⤷  Subscribe
Spain 2917549 ⤷  Subscribe
Croatia P20220998 ⤷  Subscribe
Hungary E058986 ⤷  Subscribe
Japan 2018503662 ⤷  Subscribe
Japan 2021020935 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.